2022
	Karg E, Baldow C, Zerjatke T, Clark RE, Roeder I, Fassoni AC, Glauche I Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation. Frontiers in oncology 12 (2022) 1028871, DOI Link
	Wagner S, Baldow C, Calabria A, Rudilosso L, Gallina P, Montini E, Cesana D, Glauche I Clonal reconstruction from co-occurrence of vector integration sites accurately quantifies expanding clones in vivo. Nature communications 13 (2022) 3712, DOI Link
2021
	Hoffmann H, Baldow C, Zerjatke T, Gottschalk A, Wagner S, Karg E, Niehaus S, Roeder I, Glauche I, Scherf N How to predict relapse in leukemia using time series data: A comparative in silico study. PloS one 16 (2021) e0256585, DOI Link
2020
	Hoffmann K, Cazemier K, Baldow C, Schuster S, Kheifetz Y, Schirm S, Horn M, Ernst T, Volgmann C, Thiede C, Hochhaus A, Bornhäuser M, Suttorp M, Scholz M, Glauche I, Loeffler M, Roeder I Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology. BMC medical informatics and decision making 20 (2020) 28, DOI Link
	Hähnel T, Baldow C, Guilhot J, Guilhot F, Saussele S, Mustjoki S, Jilg S, Jost PJ, Dulucq S, Mahon FX, Roeder I, Fassoni AC, Glauche I Model-based inference and classification of immunological control mechanisms from TKI cessation and dose reduction in CML patients. Cancer research 80 (2020) 2394-2406, DOI Link
2018
	Glauche I, Kuhn M, Baldow C, Schulze P, Rothe T, Liebscher H, Roy A, Wang X, Roeder I Quantitative prediction of long-term molecular response in TKI-treated CML - Lessons from an imatinib versus dasatinib comparison. Scientific Reports 8 (2018) 12330, DOI Link
	Fassoni AC, Baldow C, Roeder I, Glauche I Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: A simulation study based on phase 3 trial data Haematologica 103 (2018) 1825-1834, DOI Link
2017
	Baldow C, Salentin S, Schroeder M, Roeder I, Glauche I MAGPIE: Simplifying access and execution of computational models in the life sciences PLOS Computational Biology 13 (2017) 1-11, DOI Link
	Proschmann R, Baldow C, Rothe T, Suttorp M, Thiede C, Tauer JT, Müller MC, Hochhaus A, Roeder I, Glauche I Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy. Haematologica 102 (2017) e39-e42, DOI Link
2016
	Baldow C, Thielecke L, Glauche I Model Based Analysis of Clonal Developments Allows for Early Detection of Monoclonal Conversion and Leukemia PLoS ONE 11 (2016) e0165129, DOI Link
2015
	Isik Z, Baldow C, Cannistraci CV, Schroeder M Drug target prioritization by perturbed gene expression and network information. Scientific reports 5 (2015) 17417, DOI Link
2014
	Glauche I, Baldow Ch, Fröhlich S, Schulze P, Roy A, Subar M, Wang X, Roeder I Model-Based Characterization of the Molecular Response Dynamics of Tyrosine Kinase Inhibitor (TKI)-Treated CML Patients a Comparison of Imatinib and Dasatinib First-Line Therapy Blood 124 (2014) 4562